Let the price war begin: After Bangladesh, Sovaldi generic now in Nepal

Asia is where the buzz around the first Sovaldi (sofosbuvir) generics is happening. First Gilead firmed up licensing deals with a clutch of Indian firms putting a lid on the pricing debate on the product in the region, at least temporarily.

More from Focus On Asia

More from Scrip